Cargando…
High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472894/ https://www.ncbi.nlm.nih.gov/pubmed/32954334 http://dx.doi.org/10.1093/braincomms/fcaa085 |
_version_ | 1783579075858661376 |
---|---|
author | Ridderström, Mikael Svantesson, Mats Thorell, Oumie Magounakis, Theofilos Minde, Jan Olausson, Håkan Nagi, Saad S |
author_facet | Ridderström, Mikael Svantesson, Mats Thorell, Oumie Magounakis, Theofilos Minde, Jan Olausson, Håkan Nagi, Saad S |
author_sort | Ridderström, Mikael |
collection | PubMed |
description | In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described as hereditary sensory and autonomic neuropathy type V. The purpose of the current study was to investigate the prevalence of carpal tunnel syndrome in hereditary sensory and autonomic neuropathy type V based on clinical examinations and electrophysiological measurements. Furthermore, the cross-sectional area of the median nerve at the carpal tunnel inlet was measured with ultrasonography. Out of 52 known individuals heterozygous for the nerve growth factor-beta mutation in Sweden, 23 participated in the current study (12 males, 11 females; mean age 55 years; range 25–86 years). All participants answered a health questionnaire and underwent clinical examination followed by median nerve conduction study in a case–control design, and measurement of the nerve cross-sectional area with ultrasonography. The diagnosis of carpal tunnel syndrome was made based on consensus criteria using patient history and nerve conduction study. The prevalence of carpal tunnel syndrome in the hereditary sensory and autonomic neuropathy group was 35% or 52% depending on whether those individuals who had classic symptoms of carpal tunnel syndrome but negative nerve conduction studies were included or not. Those who had a high likelihood of carpal tunnel syndrome based on classic/probable patient history with positive nerve conduction study had a significantly larger median nerve cross-sectional area than those who had an unlikely patient history with negative nerve conduction study. The prevalence of carpal tunnel syndrome was 10–25 times higher in individuals heterozygous for the nerve growth factor-beta mutation than the general Swedish population. Further studies are needed to better understand the underlying pathophysiological mechanisms. |
format | Online Article Text |
id | pubmed-7472894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74728942020-09-17 High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation Ridderström, Mikael Svantesson, Mats Thorell, Oumie Magounakis, Theofilos Minde, Jan Olausson, Håkan Nagi, Saad S Brain Commun Original Article In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described as hereditary sensory and autonomic neuropathy type V. The purpose of the current study was to investigate the prevalence of carpal tunnel syndrome in hereditary sensory and autonomic neuropathy type V based on clinical examinations and electrophysiological measurements. Furthermore, the cross-sectional area of the median nerve at the carpal tunnel inlet was measured with ultrasonography. Out of 52 known individuals heterozygous for the nerve growth factor-beta mutation in Sweden, 23 participated in the current study (12 males, 11 females; mean age 55 years; range 25–86 years). All participants answered a health questionnaire and underwent clinical examination followed by median nerve conduction study in a case–control design, and measurement of the nerve cross-sectional area with ultrasonography. The diagnosis of carpal tunnel syndrome was made based on consensus criteria using patient history and nerve conduction study. The prevalence of carpal tunnel syndrome in the hereditary sensory and autonomic neuropathy group was 35% or 52% depending on whether those individuals who had classic symptoms of carpal tunnel syndrome but negative nerve conduction studies were included or not. Those who had a high likelihood of carpal tunnel syndrome based on classic/probable patient history with positive nerve conduction study had a significantly larger median nerve cross-sectional area than those who had an unlikely patient history with negative nerve conduction study. The prevalence of carpal tunnel syndrome was 10–25 times higher in individuals heterozygous for the nerve growth factor-beta mutation than the general Swedish population. Further studies are needed to better understand the underlying pathophysiological mechanisms. Oxford University Press 2020-06-25 /pmc/articles/PMC7472894/ /pubmed/32954334 http://dx.doi.org/10.1093/braincomms/fcaa085 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ridderström, Mikael Svantesson, Mats Thorell, Oumie Magounakis, Theofilos Minde, Jan Olausson, Håkan Nagi, Saad S High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title | High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title_full | High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title_fullStr | High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title_full_unstemmed | High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title_short | High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
title_sort | high prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472894/ https://www.ncbi.nlm.nih.gov/pubmed/32954334 http://dx.doi.org/10.1093/braincomms/fcaa085 |
work_keys_str_mv | AT ridderstrommikael highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT svantessonmats highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT thorelloumie highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT magounakistheofilos highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT mindejan highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT olaussonhakan highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation AT nagisaads highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation |